0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug/Vaccine Safety
 41-60 of 125 Articles
Original Investigation |  FREE
Rebekah W. Moehring, MD, MPH; Sarah S. Lewis, MD; Pamela J. Isaacs, BSN, MHA; et al.
JAMA Intern Med. 2014;174(4):606-612. doi:10.1001/jamainternmed.2013.13768.
Includes: Supplemental Content

Special Communication | 
Steven Woloshin, MD, MS; Lisa M. Schwartz, MD, MS
JAMA Intern Med. 2014;174(4):615-619. doi:10.1001/jamainternmed.2013.14629.

Invited Commentary | 
Seamus P. Whelton, MD, MPH; Sandeep Bansal, MD, MPH
JAMA Intern Med. 2014;174(3):345-346. doi:10.1001/jamainternmed.2013.11341.

Case Report/Case Series |  FREE
Frank M. Sacks, MD; Maxine Stanesa, PA-C; Robert A. Hegele, MD
JAMA Intern Med. 2014;174(3):443-447. doi:10.1001/jamainternmed.2013.13309.

Original Investigation |  FREE
Nathan P. Clark, PharmD; Thomas Delate, PhD; Catherine S. Riggs, PharmD; et al.
JAMA Intern Med. 2014;174(3):409-416. doi:10.1001/jamainternmed.2013.13957.
Includes: Supplemental Content

Viewpoint | 
Nathaniel P. Morris, AB
JAMA Intern Med. 2014;174(2):177-178. doi:10.1001/jamainternmed.2013.12376.

Research Letter |  FREE
Ilke Sipahi, MD; Seden Celik, MD; Nurdan Tozun, MD
JAMA Intern Med. 2014;174(1):150-151. doi:10.1001/jamainternmed.2013.12217.

Original Investigation |  FREE
Nicholas L. Smith, PhD; Marc Blondon, MD, MS; Kerri L. Wiggins, MS, RD; et al.
JAMA Intern Med. 2014;174(1):25-34. doi:10.1001/jamainternmed.2013.11074.
Includes: Supplemental Content

Invited Commentary | 
Daniel Carpenter, PhD
JAMA Intern Med. 2014;174(1):95-97. doi:10.1001/jamainternmed.2013.9202.

Original Investigation |  FREE
Thomas J. Moore, AB; Curt D. Furberg, MD, PhD
JAMA Intern Med. 2014;174(1):90-95. doi:10.1001/jamainternmed.2013.11813.

Research Letter |  FREE
Peter Doshi, PhD
JAMA Intern Med. 2013;173(21):2009-2011. doi:10.1001/jamainternmed.2013.9989.
Includes: Supplemental Content

Comment & Response | 
Arief Lalmohamed, PharmD; Niels Vermeer, PharmD; Frank de Vries, PharmD, PhD
JAMA Intern Med. 2013;173(16):1559. doi:10.1001/jamainternmed.2013.8468.

Comment & Response | 
Marcello Maggio, MD, PhD; Andrea Corsonello, MD
JAMA Intern Med. 2013;173(16):1559-1560. doi:10.1001/jamainternmed.2013.8459.

Viewpoint | 
Robert J. Smith, MD; William R. Hiatt, MD
JAMA Intern Med. 2013;173(16):1491-1492. doi:10.1001/jamainternmed.2013.6624.

Comment and Response | 
David L. Keller, MD
JAMA Intern Med. 2013;173(15):1473. doi:10.1001/jamainternmed.2013.7747.

Comment and Response | 
Brian K. Alldredge, PharmD; Steven R. Kayser, PharmD
JAMA Intern Med. 2013;173(15):1473. doi:10.1001/jamainternmed.2013.7701.

Research Letter |  FREE
Lilian M. Abbo, MD; Susan E. Beekmann, RN, MPH; Thomas M. Hooton, MD; et al.
JAMA Intern Med. 2013;173(14):1376-1378. doi:10.1001/jamainternmed.2013.6480.
Includes: Supplemental Content

Invited Commentary | 
Kent A. Sepkowitz, MD
JAMA Intern Med. 2013;173(14):1367-1368. doi:10.1001/jamainternmed.2013.7940.

Invited Commentary | 
Prescott G. Woodruff, MD, MPH
JAMA Intern Med. 2013;173(13):1184-1185. doi:10.1001/jamainternmed.2013.1201.

Original Investigation |  FREE
Andrea Gershon, MD, MS; Ruth Croxford, MSc, PStat; Andrew Calzavara, MSc; et al.
JAMA Intern Med. 2013;173(13):1175-1185. doi:10.1001/jamainternmed.2013.1016.

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Original Investigation  | 
Additive Intraocular Pressure–Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost:  A Report of 2 Randomized Clinical Trials
Hidenobu Tanihara, MD; Toshihiro Inoue, MD; Tetsuya Yamamoto, MD; et al.
JAMA Oncology
Original Investigation  | 
Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone:  Analyses of Data From 2 Women’s Health Initiative Randomized Clinical Trials
Rowan T. Chlebowski, MD, PhD; Thomas E. Rohan, PhD; JoAnn E. Manson, MD, DrPH; et al.
JAMA Oncology
Special Communication  | 
Patient-Reported Outcomes in Cancer Drug Development and US Regulatory Review:  Perspectives From Industry, the Food and Drug Administration, and the Patient
Ethan Basch, MD, MSc; Cindy Geoghegan, BA; Stephen Joel Coons, PhD; et al.
JAMA Dermatology
Viewpoint  | 
We Pledge to Change iPLEDGE
Joseph C. Pierson, MD; Laura K. Ferris, MD; Eleanor B. Schwarz, MD